Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Canada
  5. Relay Medical Corp.
  6. News
  7. Summary
    RELA   CA75943L1058


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Relay Medical : Engages Top Cybersecurity Marketing Agency Bluetext for Cybeats Product Line

07/30/2021 | 10:59am EDT
Relay Engages Top Cybersecurity Marketing Agency Bluetext for Cybeats Product Line

TORONTO, Ontario - July 30, 2021 - Relay Medical Corp. ('Relay' or the 'Company') (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) is pleased to announce it has engaged Washington, D.C. based Bluetext, a leading cybersecurity digital marketing agency, to develop and execute a powerful marketing strategy for its Cybeats product line. Bluetext has an enviable reputation of developing successful marketing strategies for technical products in the cybersecurity industry for large and small organizations.

Relay has tasked Bluetext to develop an aggressive marketing plan for the Cybeats integrated cybersecurity platform. Cybersecuritiy for the IoT industry has emerged as a priority with more and more reports of hackers gaining access to critical data through connect devices. Bluetext will work with Cybeats to develop and execute a unique but powerful marketing strategy for the cybersecurity platform.

In a recent executive order US policy makers have asked the private sector to adapt to the continuously changing threat environment, ensuring connected devices are built and operate securely. The Cybeats platform incorporates the SBOM Studio, a comprehensive tool which offers manufacturers the ability to manage, share and orchestrate software supply chain control, while automatically enriching the data with threat intelligence and implementing new standards through identification of vulnerabilities and security gaps in software components. The Cybeats SBOM Studio quantifies the risk profile of the manufacturer designed product and provides software supply chain transparency to the product users.

'Our award-winning work with cybersecurity firms at all stages of development - from global leaders to challenger brands and mature startups - is focused on creating innovative marketing campaigns that enable them to rise above the noise and efficiently achieve their business goals,' said Michael Quint, Co-President and Chief Strategy Officer of Bluetext. 'We are confident Bluetext can deliver a high-impact marketing strategy to support Relay's business and growth objectives and are honored to be selected for this assignment.'

'Bluetext has a reputation of developing very successful marketing strategies for large and small technology and cybersecurity companies and is the ideal partner for our business,' said Yoav Raiter, CEO of Relay Medical. With the Internet of Things growing at unprecedented rates, we have a challenge to educate organizations and the broader industry that rely on connected devices of the potential cyber risks and how our Cybeats solution can mitigate those vulnerabilities. I look forward to working closely with the Bluetext team to develop a creative and powerful marketing strategy with a goal of making Cybeats the leading cybersecurity solution in North America.'

SUBSCRIBE: For more information on Relay or to subscribe to the Company's mail list visit: https://www.relaymedical.com/news

About Bluetext

Bluetext is a leading digital marketing agency based in Washington, D.C. Through branding, digital marketing and public relations we help organizations of all sizes compete and win with expert strategy, powerful creative and award-winning websites, campaigns and digital experiences.

Website: www.bluetext.com

About Relay Medical Corp.

Relay Medical is a technology innovator headquartered in Toronto, Canada focused on the development of novel technologies in the diagnostics, AI data science and IoT security sectors.

Website: www.relaymedical.com


Destine Lee

Media & Communications

Relay Medical Corp.

Office. 647-872-9982

TF. 1-844-247-6633

Media Inquiries: media@relaymedical.com

Investor Relations: investor.relations@relaymedical.com

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain 'forward-looking information' within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as 'plan', 'expect', 'project', 'intend', 'believe', 'anticipate', 'estimate' and other similar words, or statements that certain events or conditions 'may' or 'will' occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at www.sedar.com

Relay MedicalJuly 30, 2021


Relay Medical Corp. published this content on 30 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 July 2021 14:58:05 UTC.

© Publicnow 2021
All news about RELAY MEDICAL CORP.
09/13RELAY MEDICAL : & Fio to Provide Rapid COVID19 Testing at the Toronto Internatio..
09/10RELAY MEDICAL : & Fio to Provide Rapid COVID-19 Testing at the Toronto Internati..
09/08Relay & Fio Announce a $750,000 Deployment of the Fionet Platform for Malaria..
09/02RELAY MEDICAL : & Fio Deployed for COVID-19 Testing to Toronto's FIFA World Cup&..
08/30Relay Medical Corp. Reports Earnings Results for the Third Quarter Ended June..
08/26RELAY MEDICAL : to Host the ‘Roots of SBOM' for their Second LIVE Webinar ..
08/26RELAY MEDICAL : Develops Home and Small Business Mobile Testing Solution
08/26Relay Medical Corp Develops Home and Small Business Mobile Testing Solution
08/24RELAY MEDICAL : & Fio Report Successful COVID-19 Testing at Tennis Canada's 2021..
08/23RELAY MEDICAL : Joint Spectroscopic and Biosensor System for Point-of-Care Testi..
More news
Financials (USD)
Sales 2021 1,23 M - -
Net income 2021 -12,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 43,1 M 42,9 M -
Capi. / Sales 2021 35,0x
Capi. / Sales 2022 1,87x
Nbr of Employees -
Free-Float 90,7%
Duration : Period :
Relay Medical Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Yoav Raiter Chief Executive Officer
W. Clark Kent President & Director
Christopher J. Hopkins Chief Financial Officer
iGAL Roytblat Chief Technology Officer
Ian Fine Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG93.04%49 551
BIOTAGE AB (PUBL)82.45%1 915